Francisco Rodríguez-Esparragón, BSc, PhD
Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jacob Lorenzo-Morales, Prof
Instituto Universitario de Enfermedades Tropicales y Salud Publica de Canarias, Universidad La Laguna
Shared therapeutic areas:
Worked with same sponsors:
Gustavo M Callicó, Prof, PhD
University of Las Palmas de Gran Canaria
Shared therapeutic areas:
Worked with same sponsors:
Himar Fabelo, BSc, PhD
Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain
Shared therapeutic areas:
Worked with same sponsors:
Jacob Lorenzo-Morales, Prof
Instituto Universitario de Enfermedades Tropicales y Salud Publica de Canarias - Universidad de La Laguna (IUETSPC-ULL)
Shared therapeutic areas:
Worked with same sponsors:
Edward G. Shaw, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Olivier Beauchet, MD
Jewish General Hospital
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Michael S Avidan, MBBcH
Washington University School of Medicine
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Tai hing Lam, MD
The University of Hong Kong
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
All 3 trials loaded